Literature DB >> 15799974

Domain interactions of the mannose 6-phosphate/insulin-like growth factor II receptor.

Jodi L Kreiling1, James C Byrd, Richard G MacDonald.   

Abstract

The mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) forms oligomeric structures important for optimal function in binding and internalization of Man-6-P-bearing extracellular ligands as well as lysosomal biogenesis and growth regulation. However, neither the mechanism of inter-receptor interaction nor the dimerization domain has yet been identified. We hypothesized that areas near the ligand binding domains of the receptor would contribute preferentially to oligomerization. Two panels of minireceptors were constructed that involved truncations of either the N- or C-terminal regions of the M6P/IGF2R encompassing deletions of various ligand binding domains. alpha-FLAG or alpha-Myc-based immunoprecipitation assays showed that all of the minireceptors tested were able to associate with a full-length, Myc-tagged M6P/IGF2R (WT-M). In the alpha-FLAG but not alpha-Myc immunoprecipitation assays, the degree of association of a series of C-terminally truncated minireceptors with WT-M showed a positive trend with length of the minireceptor. In contrast, length did not seem to affect the association of the N-terminally truncated minireceptors with WT-M, except that the 12th extracytoplasmic repeat appeared exceptionally important in dimerization in the alpha-FLAG assays. The presence of mutations in the ligand-binding sites of the minireceptors had no effect on their ability to associate with WT-M. Thus, association within the heterodimers was not dependent on the presence of functional ligand binding domains. Heterodimers formed between WT-M and the minireceptors demonstrated high affinity IGF-II and Man-6-P-ligand binding, suggesting a functional association. We conclude that there is no finite M6P/IGF2R dimerization domain, but rather that interactions between dimer partners occur all along the extracytoplasmic region of the receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799974     DOI: 10.1074/jbc.M412971200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancer.

Authors:  Jodi L Kreiling; Michelle A Montgomery; Joseph R Wheeler; Jennifer L Kopanic; Christopher M Connelly; Megan E Zavorka; Jenna L Allison; Richard G Macdonald
Journal:  FEBS J       Date:  2012-07-02       Impact factor: 5.542

2.  Structural basis for recognition of phosphodiester-containing lysosomal enzymes by the cation-independent mannose 6-phosphate receptor.

Authors:  Linda J Olson; Francis C Peterson; Alicia Castonguay; Richard N Bohnsack; Mariko Kudo; Russell R Gotschall; William M Canfield; Brian F Volkman; Nancy M Dahms
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-30       Impact factor: 11.205

3.  High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor.

Authors:  Michelle A Hartman; Jodi L Kreiling; James C Byrd; Richard G MacDonald
Journal:  FEBS J       Date:  2009-02-19       Impact factor: 5.542

4.  Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation.

Authors:  Jin Hee Lee; Thomas Palaia; Louis Ragolia
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-03       Impact factor: 4.249

5.  Cation-independent mannose 6-phosphate receptor: a composite of distinct phosphomannosyl binding sites.

Authors:  Richard N Bohnsack; Xuezheng Song; Linda J Olson; Mariko Kudo; Russell R Gotschall; William M Canfield; Richard D Cummings; David F Smith; Nancy M Dahms
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

6.  Structure and functional analysis of the IGF-II/IGF2R interaction.

Authors:  James Brown; Carlie Delaine; Oliver J Zaccheo; Christian Siebold; Robert J Gilbert; Gijs van Boxel; Adam Denley; John C Wallace; A Bassim Hassan; Briony E Forbes; E Yvonne Jones
Journal:  EMBO J       Date:  2007-11-29       Impact factor: 11.598

7.  Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth.

Authors:  Dellel Rezgui; Christopher Williams; Sharon A Savage; Stuart N Prince; Oliver J Zaccheo; E Yvonne Jones; Matthew P Crump; A Bassim Hassan
Journal:  J Mol Endocrinol       Date:  2009-02-10       Impact factor: 5.098

8.  Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member.

Authors:  Arno G Beer; Christoph Zenzmaier; Michael Schreinlechner; Jenny Haas; Martin F Dietrich; Joachim Herz; Peter Marschang
Journal:  Oncotarget       Date:  2016-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.